PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Oxycodone with naloxone - Pain
PAD Profile : Oxycodone with naloxone - Pain
Keywords :
opioids, severe pain, idiopathic restless legs syndrome' low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value, PNMP, persistent non-malignant pain
Brand Names Include :
Targinact, Myloxifin
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Oxycodone
- Co-codamol (Codeine phosphate/paracetamol)
- Tramadol hydrochloride
- Fentanyl
- Tramadol hydrochloride
- Tramadol hydrochloride
- Paracetamol
- Codeine phosphate
- Dihydrocodeine tartrate
- Buprenorphine
- Morphine sulfate
- Pregabalin
- Gabapentin
- Dronabinol/cannabidiol
- Co-dydramol (Dihydrocodeine/paracetamol)
- Ibuprofen
- Meptazinol hydrochloride
- Pethidine hydrochloride
- Diamorphine hydrochloride
- Alfentanil hydrochloride
- Co-dydramol (Dihydrocodeine/paracetamol)
- Co-dydramol (Dihydrocodeine/paracetamol)
- Nefopam hydrochloride
- Papaveretum
- Aspirin
Other Indications
Additional Documents
Type
Document
Review Date
Policy Statement
01 June 2025
Patient resource
01 January 2021
Committee Recommendations
Date
Committee Name
Narrative
22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network does not recommend the use of oxycodone and naloxone combination product
Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should:
o NOT initiate oxycodone and naloxone combination product for any new patient
AND
o De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients
In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional
Associated BNF Codes
04. Central Nervous System
04.07.02. Opioid analgesics